1. Garcia Ponte LG and Ebert U.J Eur Dermatol Vnereol 2012;26(6):9-13. 2. Niedner E, et al. Advantan Milk/Cream/Ointment in children with atopic eczema and other dermatoses – An observational study in 558 children. Act Dermatol. 2004;30:200-203. 3. Korotky NG, et al. Use of Avantan in the treatment of atop dermatitis in children. Pediatriya 2000; 5:75-78. 4. Danby SG, et al. The effect of tracolimus compared with betamethasone validate on the skin barrier in volunteers with quiescent atopic dermatitis; Br J Dermatol. 2014;170:914-21. 5. Wollenberg A, et al. Proactive treatment of atopic dermatitis in adults with 0.1% tracolimus ointment. Allergy. P2008; 63:742-50. 6. Thaçi D, et al. Proactive disease management with 0,03% tacrolimus ointment for children with atopic dermatitis. Br J Dermatol. 2008; 159: 1348-56. 7. Luger, T. (2011), Balancing efficacy and safety in the management of atopic dermatitis: the role of methylprednisolone aceponate. Journal of the European Academy of Dermatology and Venereology, 25: 251-258. doi:10.1111/j.1468-3083.2010.03789. 8. Rampini E. Methylprenisolone aceponate (MPA)*-use and clinical experience in children. J Dermatol Treat 1992; 3 (Suppl 2):27–29. 9. Alchorne MM, et al. A multicenter, comparative, open-labelled, randomized study of tolerability and efficacy of methylprednisolone aceponate and mometasone furoate in children from 2 to 14 years of age suffering from Atopic Dermatitis; Pediatria Moderna 2003; XXXIX- :275–280. 10. Haneke E, et al. The treatment of atopic dermatitis with methylprednisolone aceponate (MPA)*, a new topical corticosteroid. JDermTreat 1992; 3(2):13–15. 11. kecskes A, et al. Comparison of the local and systemic side effects of methylprednisolone aceponate and mometasone furoate applied as ointments with equal antiinflamatory activity; J Am Acad Dermatol 1993; 29:576–580. 12. Zaumseil R-P, et al. Methylprednisolone aceponate (MPA)* - a new therapeutic for eczema: a pharmacological overview; J Dermatolog Treat 1992; 3(2):3–7. 13. Wollenberg et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. JEADV 2018, 32, 657-682 14. kyllönen H, Remitz A, Mandelin JM, ElgP, Reitamo S.Effects of 1-year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitis. The British journal of dermatology. 2004 Jun; 150 (6):1174-1181. 15. Wollenberg A, et al. ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and pediatric patients. J Eur Acad Dermatol Venereol. 2016;30(5):729-47.